(Q40877335)

24 September 2017

1 reference

title

Treatment of pancreatic cancer. Promises and problems of tamoxifen, somatostatin analogs, and gemcitabine (English)

1 reference

24 September 2017

1 reference

L Rosenberg

1

1 reference

24 September 2017

1 October 1997

1 reference

International Journal of Pancreatology

24 September 2017

1 reference

24 September 2017

22

1 reference

24 September 2017

2

1 reference

24 September 2017

81-93

1 reference

Growth factors and cancer

24 September 2017

1 reference

12 December 2020

Surgical palliation for pancreatic cancer. The UCLA experience

1 reference

12 December 2020

Survival in 1001 patients with carcinoma of the pancreas

1 reference

12 December 2020

Recycling of epidermal growth factor in a human pancreatic carcinoma cell line

1 reference

12 December 2020

Treatment of pancreatic cancer: current limitations, future possibilities

1 reference

12 December 2020

A phase I clinical, plasma, and cellular pharmacology study of gemcitabine

1 reference

12 December 2020

Programmed cell death (apoptosis) in pancreatic cancers of hamsters after treatment with analogs of both luteinizing hormone-releasing hormone and somatostatin

1 reference

12 December 2020

The paradoxical effects of somatostatin on the bioactivity and production of cytotoxins derived from human peripheral blood mononuclear cells

1 reference

12 December 2020

Enhancement of tamoxifen-induced suppression of insulin-like growth factor I gene expression and serum level by a somatostatin analogue

1 reference

12 December 2020

Estrogen receptors in 7,12-dimethylbenz (a) anthracene (DMBA) induced pancreatic carcinoma in rats and in human pancreatic carcinoma.

1 reference

12 December 2020

Hormone therapy using tamoxifen in unresectable carcinoma of the pancreas--preliminary study

1 reference

12 December 2020

Antitumor effects of analogs of LH-RH and somatostatin: experimental and clinical studies

1 reference

12 December 2020

A controlled trial of combination chemotherapy with 5-FU and BCNU in pancreatic cancer

1 reference

12 December 2020

Cancer statistics, 1995.

1 reference

12 December 2020

Effect of tamoxifen on DNA synthesis and proliferation of human malignant glioma lines in vitro.

1 reference

12 December 2020

Tamoxifen therapy in unresectable adenocarcinoma of the pancreas and the papilla of Vater

1 reference

12 December 2020

Induction of a mixed ductal-squamous-islet cell carcinoma in a rat treated with a tobacco-specific carcinogen.

1 reference

12 December 2020

Induction of lung and exocrine pancreas tumors in F344 rats by tobacco-specific and Areca-derived N-nitrosamines.

1 reference

12 December 2020

Stimulation of tyrosine phosphatase and inhibition of cell proliferation by somatostatin analogues: mediation by human somatostatin receptor subtypes SSTR1 and SSTR2.

1 reference

12 December 2020

New developments in chemotherapy for patients with advanced pancreatic cancer

1 reference

12 December 2020

Somatostatin analogue octreotide enhances the antineoplastic effects of tamoxifen and ovariectomy on 7,12-dimethylbenz(alpha)anthracene-induced rat mammary carcinomas

1 reference

12 December 2020

Antiestrogen therapy in pancreatic carcinoma: a preliminary report

1 reference

12 December 2020

Effects of gastrointestinal hormones on pancreatic growth

1 reference

12 December 2020

Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients

1 reference

12 December 2020

Development of experimental cancer in the head of the pancreas by surgical induction of tissue injury.

1 reference

12 December 2020

Potentiation of the anti-proliferative effects of anti-cancer drugs by octreotide in vitro and in vivo

1 reference

12 December 2020

Biology of pancreatic cancer

1 reference

12 December 2020

Trimetrexate in locally advanced or metastatic adenocarcinoma of the pancreas. A phase II study of the Northern California Oncology Group

1 reference

12 December 2020

Cigarette smoking and pancreas cancer: a case-control study based on direct interviews

1 reference

12 December 2020

Treatment of patients with metastatic pancreatic and gastrointestinal tumours with the somatostatin analogue Sandostatin: a phase II study including endocrine effects

1 reference

12 December 2020

Phase II trial of fazarabine (arabinofuranosyl-5-azacytidine) in patients with advanced pancreatic adenocarcinoma

1 reference

12 December 2020

A phase II trial of recombinant human interferon-gamma and recombinant tumor necrosis factor in patients with advanced gastrointestinal malignancies: results of a trial terminated by excessive toxicity

1 reference

12 December 2020

Role of octreotide in the treatment of pancreatic cancer.

1 reference

12 December 2020

Effect of somatostatin and tamoxifen on the growth of human pancreatic cancers in nude mice

1 reference

12 December 2020

Effects of short-term subcutaneous administration of SMS 201-995 on calcitonin plasma levels in patients suffering from medullary thyroid carcinoma

1 reference

12 December 2020

Randomized study of 5-FU and CCNU in pancreatic cancer: report of the Veterans Administration Surgical Adjuvant Cancer Chemotherapy Study Group

1 reference

12 December 2020

Low dose octreotide and tamoxifen in the treatment of adenocarcinoma of the pancreas

1 reference

12 December 2020

Phase II trial of edatrexate in patients with advanced pancreatic adenocarcinoma

1 reference

12 December 2020

Role of c-myc in tamoxifen-induced apoptosis estrogen-independent breast cancer cells

1 reference

12 December 2020

Somatostatin and somatostatin analogues in oncology

1 reference

12 December 2020

Survival benefit of tamoxifen therapy in adenocarcinoma of pancreas. A case-control study

1 reference

12 December 2020

Pancreatic adenocarcinoma: epidemiology and genetics

1 reference

12 December 2020

Effect of tamoxifen on serum insulinlike growth factor I levels in stage I breast cancer patients

1 reference

12 December 2020

Pancreatic cancer: the greatest oncological challenge

1 reference

12 December 2020

Phase II study of amonafide in advanced pancreatic adenocarcinoma

1 reference

12 December 2020

1 reference

12 December 2020

Clinical trial of tamoxifen in patients with irresectable pancreatic adenocarcinoma. The Yorkshire Gastrointestinal Tumour Group.

1 reference

12 December 2020

Oestrogen receptor proteins in malignant and fetal pancreas

1 reference

12 December 2020

Relative potencies of the somatostatin analogs octreotide, BIM-23014, and RC-160 on the inhibition of hormone release by cultured human endocrine tumor cells and normal rat anterior pituitary cells.

1 reference

12 December 2020

Phase II trial of gemcitabine (2,2'-difluorodeoxycytidine) in patients with adenocarcinoma of the pancreas

1 reference

12 December 2020

Smoking and cancer with emphasis on Europe

1 reference

12 December 2020

A comparison of the relative chemosensitivity of human gliomas to tamoxifen and n-desmethyltamoxifen in vitro.

1 reference

12 December 2020

Comparison of the cellular pharmacokinetics and toxicity of 2',2'-difluorodeoxycytidine and 1-beta-D-arabinofuranosylcytosine

1 reference

12 December 2020

Biological activity and receptor binding characteristics to various human tumors of acetylated somatostatin analogs

1 reference

12 December 2020

Effects of tamoxifen on growth and apoptosis of estrogen-dependent and -independent human breast cancer cells

1 reference

12 December 2020

Somatostatin analogues inhibit growth of pancreatic cancer by stimulating tyrosine phosphatase

1 reference

12 December 2020

Low-dose octreotide treatment is not effective in patients with advanced pancreatic cancer

1 reference

12 December 2020

Comparison of somatostatin and its highly potent hexa- and octapeptide analogs on exocrine and endocrine pancreatic secretion

1 reference

12 December 2020

Cytotoxic analog of somatostatin containing methotrexate inhibits growth of MIA PaCa-2 human pancreatic cancer xenografts in nude mice

1 reference

12 December 2020

A rationale for expanding the endpoints for clinical trials in advanced pancreatic carcinoma

1 reference

12 December 2020

Cancer of the pancreas. 50 years of surgery

1 reference

12 December 2020

Epidemiology of pancreatic cancer

1 reference

12 December 2020

Promoting effect of truncal vagotomy on pancreatic carcinogenesis initiated with N-nitrosobis(2-oxopropyl)amine in Syrian golden hamsters

1 reference

12 December 2020

A phase III trial on the therapy of advanced pancreatic carcinoma. Evaluations of the Mallinson regimen and combined 5-fluorouracil, doxorubicin, and cisplatin

1 reference

12 December 2020

The integration of chemotherapy into a combined modality approach for cancer treatment. VI. Pancreatic adenocarcinoma

1 reference

12 December 2020

Suppression of superoxide release from human monocytes by somatostatin-related peptides

1 reference

12 December 2020

Gemcitabine for pancreatic cancer: how hard to look for clinical benefit? An American perspective

1 reference

12 December 2020

Membrane receptors for peptides in experimental and human pancreatic cancers

1 reference

12 December 2020

Protein kinase C inhibitors induce apoptosis in human malignant glioma cell lines

1 reference

12 December 2020

Evaluation of the antitumor activity of gemcitabine (2',2'-difluoro-2'-deoxycytidine).

1 reference

12 December 2020

Potential role of somatostatin analogues in the treatment of cancer

1 reference

12 December 2020

Evaluation of combination chemotherapy and phase II agents in pancreatic adenocarcinoma. A Southwest Oncology Group study

1 reference

12 December 2020

Adenocarcinoma of the pancreas--a hormone sensitive tumor? A preliminary report on Nolvadex treatment

1 reference

12 December 2020

Steroid receptors in exocrine glands: The pancreas and prostate

1 reference

12 December 2020

A study of tobacco carcinogenesis: effect of the fat content of the diet on the carcinogenic activity of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in F344 rats

1 reference

12 December 2020

Inhibitory effects of analogs of luteinizing hormone-releasing hormone and somatostatin on pancreatic cancers in hamsters. Events that accompany tumor regression

1 reference

12 December 2020

Effects of chronic administration of somatostatin on rat exocrine pancreas

1 reference

12 December 2020

Absence of somatostatin receptors in human exocrine pancreatic adenocarcinomas

1 reference

12 December 2020

Somatostatin analogue SMS 201-995 reduces serum IGF-I levels in patients with neoplasms potentially dependent on IGF-I.

1 reference

12 December 2020

Long-term treatment of a VIPoma with somatostatin analogue resulting in remission of symptoms and possible shrinkage of metastases

1 reference

12 December 2020

Role of epidermal growth factor in carcinogenesis.

1 reference

12 December 2020

Inhibition of growth of two human pancreatic adenocarcinomas in vivo by somatostatin analog SMS 201-995.

1 reference

12 December 2020

Cholecystokinin inhibits DNA alkylation induced by N-nitrosobis (2-oxopropyl)amine (BOP) in hamster pancreas

1 reference

12 December 2020

Phase II evaluation of iproplatin in patients with advanced gastric and pancreatic cancer

1 reference

12 December 2020

Phase I trial of recombinant human gamma-interferon and recombinant human tumor necrosis factor in patients with advanced gastrointestinal cancer

1 reference

12 December 2020

Endocrine-responsive pancreatic carcinoma: steroid binding and cytotoxicity studies in human tumor cell lines.

1 reference

12 December 2020

Treatment of nitrosamine-induced pancreatic tumors in hamsters with analogs of somatostatin and luteinizing hormone-releasing hormone

1 reference

12 December 2020

Chemotherapy in pancreatic cancer: results of a controlled, prospective, randomised, multicentre trial.

1 reference

12 December 2020

A phase II study to evaluate tamoxifen in pancreatic adenocarcinoma

1 reference

12 December 2020

Purification and partial characterization of a 17 beta-estradiol-binding macromolecule in the human pancreas

1 reference

12 December 2020

The use of chemotherapy in the treatment of advanced gastric and pancreas cancer.

1 reference

12 December 2020

Collective review of small carcinomas of the pancreas

1 reference

12 December 2020

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

1 reference

12 December 2020

Effect of the long-acting somatostatin analogue SMS 201-995 (Sandostatin) in advanced breast cancer

1 reference

12 December 2020

All five cloned human somatostatin receptors (hSSTR1-5) are functionally coupled to adenylyl cyclase

1 reference

12 December 2020

The beneficial effect of tamoxifen therapy in patients with resected adenocarcinoma of the pancreas

1 reference

12 December 2020

Nicotine-derived N-nitrosamines (TSNA) and their relevance in tobacco carcinogenesis

1 reference

12 December 2020

A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer

1 reference

12 December 2020

Identifiers

0 references

1 reference

PubMed ID

9387029